Summary:
Click image to enlargeRandomized, Double-blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy, Safety and Immunogenicity of Vaccination with ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia coli Disease in Adults Aged 60 Years and Older with a History of Urinary Tract Infection in the Past 2 Years
Criteria:- Must be 60 and older.
- History of UTI in the past 2 years.
- Not pregnant or trying to get pregnant.
Qualified Participants May Receive:
Qualified participants will receive a breakdown of $ 1,175.00.
- In office visits: $125.00
- Safety phone calls: $25.00